Which antibiotics increase risk of sudden death in your patient on haemodialysis? Probably something you should know. Check out our rapid-fire summary tweetorial at the link!
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
Which antibiotics increase risk of sudden death in your patient on haemodialysis? Probably something you should know. Check out our rapid-fire summary tweetorial at the link!
⚖️As doctors we guide our practice by the principle: primum, non nocere
— Nephrology Jrnl Club (@NephJC) July 22, 2022
⁉️ Premise: pt on hemodialysis develops pneumonia. What antibiotic would you use?
Welcome to #TenTweetNephJC
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/PHeR0c7EkV